Karol Bowens
Obstetrics · Lynwood, CANPI 1083798284
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 27.8% of the total. Reporting peaked in 2023 at $847 and has fallen 58.8% since, to $349 in 2025.
Across 156 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sumitomo Pharma America, Inc.$443
- Applied Medical Resources Corporation$300
- Exeltis, USA Inc.$251
- Organon$251
- Mayne Pharma Commercial LLC$207
- plus $1K from 23 others
What the payments were for
- Travel & lodging$2597%
- Food & beverage$3,49493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $1,044 |
| Sumitomo Pharma America, Inc. | 17 | $443 |
| Applied Medical Resources Corporation | 2 | $300 |
| Exeltis, USA Inc. | 13 | $251 |
| Organon | 13 | $251 |
| Mayne Pharma Commercial LLC | 10 | $207 |
| Evofem Biosciences, Inc. | 17 | $195 |
| Merck | 10 | $176 |
| Astellas Pharma US Inc | 5 | $138 |
| Hologic Sales And Service, LLC | 5 | $124 |
| Bayer | 4 | $86 |
| Myovant Sciences Inc. | 3 | $61 |
| Smith+Nephew | 3 | $48 |
| Therapeuticsmd, Inc. | 3 | $48 |
| Mylan Pharmaceuticals Inc. | 2 | $44 |
| Millicent US Inc | 2 | $42 |
| Roche Diagnostics Corporation | 2 | $38 |
| Baxter Healthcare | 1 | $34 |
| Shield Therapeutics Inc | 1 | $33 |
| Biom'up France SAS | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Pfizer | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $21 |
| GSK | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Viiv Healthcare Company | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$259
How this compares
$3,753 in reported general payments places this provider in the 85th percentile of 119 obstetrics providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 34 | $1,241 |
| Clotrimazole | 12 | $87 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Lynwood
- Peter WangGarden Grove$428K
- Douglas Woelkersla Jolla$57K
- Richard FriedmanBurbank$18K
- Jennifer ByerSanta Rosa$17K
- Omar AzizEl Centro$14K
- Frederica LofquistSan Francisco$14K
- Craig SafferSan Diego$14K
- Caitlyn PainterSan Francisco$10K
- Kay DanielsStanford$9K
- Joie RussoEncino$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.